184 related articles for article (PubMed ID: 6707911)
21. A genetic fusion construct between the tetanus toxin C fragment and the lysosomal acid hydrolase beta-glucuronidase expresses a bifunctional protein with enhanced secretion and neuronal uptake.
Jiang K; Watson DJ; Wolfe JH
J Neurochem; 2005 Jun; 93(5):1334-44. PubMed ID: 15934952
[TBL] [Abstract][Full Text] [Related]
22. Fragment A-B of tetanus toxin does not block neuromuscular transmission in the goldfish.
Mellanby J; Matsuda M; Sugimoto N; Lei DL; Bizzini B
Toxicon; 1990; 28(6):737-41. PubMed ID: 2169660
[TBL] [Abstract][Full Text] [Related]
23. Immunization does not interfere with uptake and transport by motor neurons of the binding fragment of tetanus toxin.
Fishman PS; Matthews CC; Parks DA; Box M; Fairweather NF
J Neurosci Res; 2006 Jun; 83(8):1540-3. PubMed ID: 16557581
[TBL] [Abstract][Full Text] [Related]
24. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
[TBL] [Abstract][Full Text] [Related]
25. Activity-dependent changes in partial VAMP complexes during neurotransmitter release.
Hua SY; Charlton MP
Nat Neurosci; 1999 Dec; 2(12):1078-83. PubMed ID: 10570484
[TBL] [Abstract][Full Text] [Related]
26. Chains and fragments of tetanus toxin, and their contribution to toxicity.
Ahnert-Hilger G; Dauzenroth ME; Habermann E; Henschen A; Krieglstein K; Mauler F; Weller U
J Physiol (Paris); 1990; 84(3):229-36. PubMed ID: 2074546
[TBL] [Abstract][Full Text] [Related]
27. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
[TBL] [Abstract][Full Text] [Related]
28. A means for targeting therapeutics to peripheral nervous system neurons with axonal damage.
Federici T; Liu JK; Teng Q; Yang J; Boulis NM
Neurosurgery; 2007 May; 60(5):911-8; discussion 911-8. PubMed ID: 17460527
[TBL] [Abstract][Full Text] [Related]
29. [Production of recombinant fragments of the Clostridium tetani neurotoxin for the development of new immune-prophylaxis preparations against tetanus].
Varfolomeeva NA; Makhotina OA; Sergeeva TI; Belyĭ IuF
Mol Gen Mikrobiol Virusol; 2003; (3):29-33. PubMed ID: 12966924
[TBL] [Abstract][Full Text] [Related]
30. C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor.
Herreros J; Lalli G; Schiavo G
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):199-204. PubMed ID: 10727419
[TBL] [Abstract][Full Text] [Related]
31. Cooperative action of the light chain of tetanus toxin and the heavy chain of botulinum toxin type A on the transmitter release of mammalian motor endplates.
Weller U; Dauzenroth ME; Gansel M; Dreyer F
Neurosci Lett; 1991 Jan; 122(1):132-4. PubMed ID: 1676142
[TBL] [Abstract][Full Text] [Related]
32. Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons.
Herreros J; Lalli G; Montecucco C; Schiavo G
J Neurochem; 2000 May; 74(5):1941-50. PubMed ID: 10800937
[TBL] [Abstract][Full Text] [Related]
33. Characterization of fragment C and tetanus toxin binding to rat brain membranes.
Goldberg RL; Costa T; Habig WH; Kohn LD; Hardegree MC
Mol Pharmacol; 1981 Nov; 20(3):565-70. PubMed ID: 6120449
[No Abstract] [Full Text] [Related]
34. Inhibition of tetanus toxin fragment C binding to ganglioside G(T1b) by monoclonal antibodies recognizing different epitopes.
Fitzsimmons SP; Clark KC; Wilkerson R; Shapiro MA
Vaccine; 2000 Aug; 19(1):114-21. PubMed ID: 10924793
[TBL] [Abstract][Full Text] [Related]
35. Molecular pharmacology of botulinum toxin and tetanus toxin.
Simpson LL
Annu Rev Pharmacol Toxicol; 1986; 26():427-53. PubMed ID: 3521461
[No Abstract] [Full Text] [Related]
36. Binding to the high-affinity M-type receptor for secreted phospholipases A(2) is not obligatory for the presynaptic neurotoxicity of ammodytoxin A.
Prijatelj P; Vardjan N; Rowan EG; Krizaj I; Pungercar J
Biochimie; 2006 Oct; 88(10):1425-33. PubMed ID: 16815622
[TBL] [Abstract][Full Text] [Related]
37. The HC fragment of tetanus toxin forms stable, concentration-dependent dimers via an intermolecular disulphide bond.
Qazi O; Bolgiano B; Crane D; Svergun DI; Konarev PV; Yao ZP; Robinson CV; Brown KA; Fairweather N
J Mol Biol; 2007 Jan; 365(1):123-34. PubMed ID: 17056064
[TBL] [Abstract][Full Text] [Related]
38. [The structure and mechanism of action of clostridial neurotoxins].
Parasion S; Bartoszcze M; Gryko R
Przegl Epidemiol; 2007; 61(3):519-27. PubMed ID: 18069389
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the binding and internalization of tetanus toxin in a neuroblastoma hybrid cell line.
Staub GC; Walton KM; Schnaar RL; Nichols T; Baichwal R; Sandberg K; Rogers TB
J Neurosci; 1986 May; 6(5):1443-51. PubMed ID: 3711989
[TBL] [Abstract][Full Text] [Related]
40. Retargeting of adenoviral vectors to neurons using the Hc fragment of tetanus toxin.
Schneider H; Groves M; Mühle C; Reynolds PN; Knight A; Themis M; Carvajal J; Scaravilli F; Curiel DT; Fairweather NF; Coutelle C
Gene Ther; 2000 Sep; 7(18):1584-92. PubMed ID: 11021597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
